Suppr超能文献

评估 [ F]FDG-PET/CT 检测结直肠和其他解剖部位摄取以及免疫炎症性外周血指标在一线免疫检查点抑制剂治疗晚期非小细胞肺癌患者中的作用。

Assessing the role of colonic and other anatomical sites uptake by [ F]FDG-PET/CT and immune-inflammatory peripheral blood indexes in patients with advanced non-small cell lung cancer treated with first-line immune checkpoint inhibitors.

机构信息

Candiolo Cancer Institute, FPO-IRCCS, Turin, Italy.

Department of Oncology, University of Turin, San Luigi Hospital, Turin, Italy.

出版信息

Thorac Cancer. 2023 Aug;14(24):2473-2483. doi: 10.1111/1759-7714.15032. Epub 2023 Jul 13.

Abstract

BACKGROUND

Inflammation in non-small cell lung cancer (NSCLC) may impair the response to immune checkpoint inhibitors (ICIs) and can be indicated by peripheral blood inflammatory indexes. 2-deoxy-2-[ F]fluoro-D-glucose positron emission tomography/computed tomography ([ F] FDG-PET/CT) may be used as a marker of inflammation by measuring glucose metabolism in different colonic sites.

METHODS

This retrospective analysis aimed to investigate the correlation between [ F] FDGPET/CT SUV in six gastrointestinal districts, the spleen, the pharynx and the larynx alongside the most avid tumor lesion with peripheral blood inflammatory indexes, including the neutrophil-to-lymphocyte ratio (NLR), systemic immune-inflammatory index (SII, i.e., NLR times platelets) and lactate dehydrogenase (LDH), in patients with [ F] FDG-PET/CT staged IV NSCLC who received first-line immune checkpoint inhibitors (ICIs). The role of SUV and peripheral blood inflammatory indexes in predicting overall survival (OS) and progression-free survival (PFS) was then explored.

RESULTS

A total of 43 patients were treated with first-line ICI alone (58%) or in combination with chemotherapy (42%). A significant correlation was only found between the rectosigmoid SUV and NLR (p = 0.0465). NLR >5.5 and LDH > 333.5 were associated with a worse OS (p = 0.033 and p = 0.009, respectively). The SII was associated with a worse PFS in patients treated with ICI alone (p = 0.033). None of the SUV were significantly associated with OS or PFS, although a high left colon SUV showed a trend toward a worse PFS.

CONCLUSION

There was no significant correlation between [ F]FDG PET/CT uptake in different anatomical sites, and in the tumor, and systemic immune-inflammatory indexes. The prognostic role of high left colon SUV deserves further investigation.

摘要

背景

非小细胞肺癌(NSCLC)中的炎症可能会影响免疫检查点抑制剂(ICI)的反应,外周血炎症指标可以提示炎症。2-脱氧-2-[F]氟-D-葡萄糖正电子发射断层扫描/计算机断层扫描([F]FDG-PET/CT)可以通过测量不同结直肠部位的葡萄糖代谢来作为炎症的标志物。

方法

本回顾性分析旨在研究 IV 期 NSCLC 患者行[F]FDG-PET/CT 分期后,接受一线免疫检查点抑制剂(ICI)治疗时,六个胃肠道区域、脾脏、咽和喉的[F]FDG-PET/CT SUV 与外周血炎症指标(包括中性粒细胞与淋巴细胞比值(NLR)、全身性免疫炎症指数(SII,即 NLR 乘以血小板)和乳酸脱氢酶(LDH))之间的相关性。然后探讨 SUV 和外周血炎症指标对总生存期(OS)和无进展生存期(PFS)的预测作用。

结果

共有 43 例患者单独接受一线 ICI 治疗(58%)或联合化疗(42%)。仅直肠乙状结肠 SUV 与 NLR 之间存在显著相关性(p=0.0465)。NLR>5.5 和 LDH>333.5 与 OS 较差相关(p=0.033 和 p=0.009)。单独接受 ICI 治疗的患者中,SII 与 PFS 较差相关(p=0.033)。虽然左半结肠 SUV 较高与 PFS 较差有一定趋势,但 SUV 与 OS 或 PFS 之间均无显著相关性。

结论

不同解剖部位和肿瘤摄取[F]FDG-PET/CT 与全身免疫炎症指标之间无显著相关性。左半结肠 SUV 较高的预后作用值得进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8cd/10447168/d70b1263e41a/TCA-14-2473-g003.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验